Microbot Medical (NASDAQ:MBOT) and CVR Medical (OTCMKTS:CRRVF) Critical Contrast

CVR Medical (OTCMKTS:CRRVFGet Free Report) and Microbot Medical (NASDAQ:MBOTGet Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.

Profitability

This table compares CVR Medical and Microbot Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CVR Medical N/A N/A N/A
Microbot Medical N/A -218.30% -158.17%

Analyst Ratings

This is a breakdown of current ratings and price targets for CVR Medical and Microbot Medical, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVR Medical 0 0 0 0 0.00
Microbot Medical 0 0 1 0 3.00

Microbot Medical has a consensus target price of $7.00, indicating a potential upside of 354.55%. Given Microbot Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than CVR Medical.

Valuation & Earnings

This table compares CVR Medical and Microbot Medical”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CVR Medical N/A N/A -$1.82 million N/A N/A
Microbot Medical N/A N/A -$10.74 million ($0.80) -1.92

Institutional & Insider Ownership

16.3% of Microbot Medical shares are held by institutional investors. 10.5% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Microbot Medical beats CVR Medical on 5 of the 8 factors compared between the two stocks.

About CVR Medical

(Get Free Report)

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About Microbot Medical

(Get Free Report)

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Receive News & Ratings for CVR Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVR Medical and related companies with MarketBeat.com's FREE daily email newsletter.